| Financial Year |
March 31 2023 |
| Monetary Funds |
2,012,449,867.53 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,819,944.15 |
| Accounts Receivable |
1,371,885,017.11 |
| Advances to Suppliers |
110,625,601.20 |
| Other Receivables |
234,276,351.98 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
239,271.90 |
| Dividend Receivable |
-- |
| Inventories |
7,928,902,482.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
17,658,813.93 |
| Other Current Assets |
244,402,565.23 |
| Total Current Assets |
11,944,131,875.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
12,762,035.22 |
| Long-term Equity Investment |
798,642,806.10 |
| Investment Properties |
3,042,219,918.28 |
| Fixed Assetes |
206,463,668.93 |
| Under-construction Projects |
126,865,190.26 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
255,924,214.28 |
| R&D expenses |
-- |
| Goodwill |
60,046,756.00 |
| Long-Term Deferred and Prepaid Expenses |
309,969,748.79 |
| Deferred Income Tax Assets |
678,123,263.61 |
| Other Non-Current Assets |
7,119,423.78 |
| Sub-Total of Non-Current Assets |
7,395,731,099.08 |
| Total Assets |
19,339,862,974.15 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,798,257.41 |
| Accounts Payable |
1,646,074,387.83 |
| Accounts Received In Advance |
48,250,867.43 |
| Employee Compensation Payable |
41,337,551.87 |
| Taxes Payable |
864,325,964.11 |
| Interest Payable |
16,640,995.44 |
| Dividend Payable |
1,485,000.00 |
| Other payables |
386,784,785.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,650,804,785.89 |
| Other Current Liabilities |
1,272,326,862.69 |
| Sub-Total of Current Liabilities |
7,059,387,373.45 |
| Long-term Loans |
764,615,998.60 |
| Bonds Payable |
2,023,064,823.15 |
| Long-Term Accounts Payable |
33,938,810.42 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
52,963,856.29 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,200,869,978.08 |
| Total Liabilities |
11,260,257,351.53 |
| Paid-In Capital(Or Share Stock) |
1,118,585,045.00 |
| Capital Surplus |
2,661,697,144.50 |
| Surplus Reserve |
234,927,029.89 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,611,809,994.77 |
| Minority Stockholder's Interest |
371,630,720.05 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,707,974,902.57 |
| Owner's Equity（Stockholder's Equity） |
8,079,605,622.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
19,339,862,974.15 |
